Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex

Go back to Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Ex
PARTNERRE LTD. (NASDAQ: PRE) Delayed: 17.35 +0.78 (4.71%)
Previous Close $16.57    52 Week High $141.25 
Open $16.82    52 Week Low $111.52 
Day High $17.85    P/E 1.64 
Day Low $16.81    EPS $10.58 
Volume 160,623       

PARTNERRE LTD. (NASDAQ: PRE) Delayed: 17.35 +0.78 (4.71%)
Previous Close $16.57    52 Week High $141.25 
Open $16.82    52 Week Low $111.52 
Day High $17.85    P/E 1.64 
Day Low $16.81    EPS $10.58 
Volume 160,623       

PARTNERRE LTD. (NASDAQ: PRE) Delayed: 17.35 +0.78 (4.71%)
Previous Close $16.57    52 Week High $141.25 
Open $16.82    52 Week Low $111.52 
Day High $17.85    P/E 1.64 
Day Low $16.81    EPS $10.58 
Volume 160,623